TURNOVER (x1000 SEK)
NET PROFIT (x1000 SEK)
EMPLOYEES
Unimedic Pharma AB
Closing information (x1000 SEK)
Closing information | 2023/12 | 2022/12 | 2021/12 |
Turnover |
381,109
|
315,501
|
248,248 |
Financial expenses |
3,798
|
2,131
|
1,079 |
Earnings before taxes |
73,166
|
67,543
|
30,172 |
EBITDA |
82,828
|
76,665
|
37,533 |
Total assets |
199,418
|
198,791
|
136,559 |
Current assets |
184,398
|
176,807
|
112,955 |
Current liabilities |
57,505
|
85,020
|
60,823 |
Equity capital |
75,687
|
36,870
|
20,218 |
- share capital |
200
![]() |
200
![]() |
200 |
Employees (average) |
27
![]() |
27
|
25 |
Financial ratios
Fiscal year | 2023/12 | 2022/12 | 2021/12 |
Solvency |
38.0%
|
18.5%
|
14.8% |
Turnover per employee |
14,115
|
11,685
|
9,930 |
Profit as a percentage of turnover |
19.2%
|
21.4%
|
12.2% |
Return on assets (ROA) |
38.6%
|
35.0%
|
22.9% |
Current ratio |
320.7%
|
208.0%
|
185.7% |
Return on equity (ROE) |
96.7%
|
183.2%
|
149.2% |
Change turnover |
65,608
|
67,253
|
5,403 |
Change turnover % |
21%
|
27%
|
2% |
Chg. No. of employees |
0
|
2
![]() |
2 |
Chg. No. of employees % |
0%
|
8%
|
9% |
Total value of public sale
Fiscal year | 2023/12 | 2022/12 | 2021/12 |
Total value of public sale |
0
![]() |
0
![]() |
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.